ReviewPain management2025
Medical management of musculoskeletal pain in professional wheelchair basketball players: an evidence-based guide.
Review in Pain management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wheelchair basketball (WB) has evolved from a recreational activity to an internationally recognized sport. It is useful in enhancing psychophysical well-being in athletes with disabilities. However, WB professional players' medical management, especially regarding musculoskeletal pain (MSP), poses unique challenges and the related scientific literature still seems fragmentary. An extensive review of the PubMed, Cochrane, and Embase databases was performed to identify the available evidence regarding the medical management of WB players MSP. It emerges that WB players often face musculoskeletal injuries due to repetitive movements and game-specific actions. The management of these injuries requires a multidisciplinary approach. Firstly, the use of pharmacological treatments like Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is common, though care must be taken to comply with World Anti-Doping Agency (WADA) regulations. Then, preventive strategies, including tailored rehabilitation and strength conditioning, are essential. Moreover, the use of dietary supplements, while popular for enhancing recovery and performance, carries risks, particularly contamination with prohibited substances. Therefore, medical staff must exercise caution when recommending supplements. Finally, this review highlights that WB players' MSP management requires balancing effective treatment with adherence to anti-doping rules, limiting the use of traditional drugs where possible and improving the clinical application of non-pharmacological treatments, such as physical and rehabilitation medicine approaches.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.